| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,857 |
36,152 |
$1.57M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,719 |
23,611 |
$1.40M |
| 95816 |
|
2,405 |
685 |
$336K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,997 |
4,642 |
$185K |
| 99490 |
Ccm add 20min |
7,634 |
6,708 |
$150K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
5,063 |
3,803 |
$149K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
4,616 |
3,792 |
$109K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,479 |
1,271 |
$104K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,132 |
655 |
$94K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
638 |
100 |
$75K |
| 99223 |
Prolong inpt eval add15 m |
964 |
733 |
$74K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
433 |
413 |
$48K |
| 93923 |
|
417 |
298 |
$37K |
| 99439 |
|
2,011 |
1,770 |
$32K |
| 95957 |
|
310 |
254 |
$30K |
| 93925 |
|
356 |
323 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
2,305 |
2,015 |
$29K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
255 |
234 |
$26K |
| 96112 |
|
2,061 |
621 |
$26K |
| 93880 |
|
333 |
266 |
$23K |
| 20611 |
|
667 |
513 |
$22K |
| 72100 |
|
1,133 |
1,031 |
$21K |
| 93000 |
|
1,901 |
1,620 |
$17K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
361 |
331 |
$17K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
271 |
248 |
$16K |
| 93922 |
|
317 |
271 |
$13K |
| 94729 |
|
660 |
572 |
$13K |
| 94060 |
|
706 |
611 |
$13K |
| 99487 |
Ccm add 20min |
537 |
512 |
$13K |
| G3002 |
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) |
390 |
357 |
$12K |
| 99233 |
Prolong inpt eval add15 m |
174 |
153 |
$11K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
319 |
266 |
$10K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
100 |
94 |
$10K |
| 99318 |
|
262 |
207 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
287 |
229 |
$7K |
| 90901 |
|
1,837 |
502 |
$7K |
| 94726 |
|
405 |
364 |
$7K |
| 99489 |
Ccm add 20min |
381 |
378 |
$7K |
| 94727 |
|
450 |
378 |
$7K |
| 72040 |
|
335 |
298 |
$6K |
| 94200 |
|
754 |
662 |
$5K |
| 99484 |
|
678 |
556 |
$5K |
| 99215 |
Prolong outpt/office vis |
86 |
58 |
$5K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
28 |
27 |
$4K |
| 98925 |
|
360 |
283 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
47 |
44 |
$4K |
| 93970 |
|
71 |
63 |
$4K |
| 92546 |
|
128 |
104 |
$4K |
| 72131 |
|
64 |
52 |
$4K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
164 |
115 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
71 |
55 |
$3K |
| 95812 |
|
41 |
33 |
$3K |
| 73030 |
|
229 |
177 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
35 |
27 |
$2K |
| 95115 |
|
485 |
181 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
455 |
399 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
308 |
269 |
$2K |
| 94664 |
|
398 |
359 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
483 |
414 |
$2K |
| 80061 |
Lipid panel |
313 |
270 |
$2K |
| 97129 |
|
816 |
265 |
$2K |
| 80053 |
Comprehensive metabolic panel |
345 |
301 |
$2K |
| 99457 |
|
196 |
156 |
$2K |
| 95923 |
|
35 |
34 |
$1K |
| 73560 |
|
100 |
86 |
$1K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
351 |
198 |
$1K |
| 93050 |
|
154 |
142 |
$1K |
| 99310 |
Prolong nursin fac eval 15m |
16 |
14 |
$1K |
| 72070 |
|
56 |
48 |
$888.25 |
| 95921 |
|
26 |
24 |
$878.68 |
| 99306 |
Prolong nursin fac eval 15m |
12 |
12 |
$852.13 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
48 |
48 |
$770.40 |
| 99205 |
Prolong outpt/office vis |
17 |
12 |
$736.35 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
79 |
63 |
$711.18 |
| 92542 |
|
81 |
60 |
$711.01 |
| 99458 |
|
45 |
39 |
$673.82 |
| 96116 |
|
170 |
81 |
$667.83 |
| 99382 |
|
26 |
26 |
$615.00 |
| 96132 |
|
124 |
112 |
$519.96 |
| 94010 |
|
33 |
27 |
$451.42 |
| 95250 |
|
12 |
12 |
$413.71 |
| 69210 |
|
38 |
21 |
$391.34 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
24 |
14 |
$383.01 |
| 99442 |
|
45 |
35 |
$355.16 |
| 97533 |
|
72 |
33 |
$346.88 |
| 99406 |
|
76 |
53 |
$333.97 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
19 |
17 |
$290.89 |
| 92540 |
|
23 |
19 |
$272.76 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
46 |
46 |
$224.14 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
167 |
136 |
$201.31 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16 |
16 |
$189.44 |
| 36415 |
Collection of venous blood by venipuncture |
359 |
305 |
$185.96 |
| 92547 |
|
127 |
103 |
$175.30 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
131 |
70 |
$160.25 |
| 99441 |
|
19 |
17 |
$152.80 |
| 84481 |
|
13 |
12 |
$152.44 |
| 96136 |
|
12 |
12 |
$113.27 |
| 95251 |
|
12 |
12 |
$97.85 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18 |
14 |
$88.52 |
| 99454 |
|
22 |
14 |
$81.30 |
| 99453 |
|
39 |
32 |
$65.55 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
83 |
70 |
$59.68 |
| 84439 |
|
12 |
12 |
$57.68 |
| 82962 |
|
27 |
26 |
$57.64 |
| K1034 |
Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count |
213 |
209 |
$24.00 |
| 96127 |
|
14 |
13 |
$5.76 |
| 1159F |
|
128 |
102 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,018 |
920 |
$0.00 |
| 90756 |
|
79 |
61 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
21 |
18 |
$0.00 |
| 0521F |
|
103 |
92 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
24 |
19 |
$0.00 |
| 1125F |
|
212 |
193 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
89 |
69 |
$0.00 |
| 80376 |
|
24 |
12 |
$0.00 |
| 3008F |
|
37 |
34 |
$0.00 |